Navigation Links
Cost Effective Solution for Patient Testing: Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy
Date:8/31/2009

SAN DIEGO, Aug. 31 /PRNewswire/ -- San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.

"Until now, lack of a single testing platform has resulted in fragmenting the diagnostic market, forcing laboratories to adopt number of alternative methods such as traditional culture, serology and probe based DNA testing," says Dr. Moorthy, President and Founder of MultiGEN Diagnostics. "Present test methods have increased cost of testing, and hence, all clinically relevant targets are not tested routinely. The use of a single, reliable and versatile single-platform technology (MultiGEN) for testing diverse clinical sample unifies testing procedures and reduces cost significantly. MultiGEN's unique features will exceed end-user expectations, and thereby encourage further use of molecular diagnostics in clinical markets."

MultiGEN's patented platform technology allows detection and confirmation of multiple targets simultaneously using unmatched DNA sequencing, while still maintaining the highest possible sensitivity and specificity. These tests include panels for common pathogens causing an infectious syndrome (e.g. STDs - sexually transmitted diseases), acquired mutations in cancer that affect the response to drugs (e.g. K-ras, EGFR mutations for colo-rectal cancer therapy), and genetic predisposition to disease (e.g. Thrombophilia panel with Factor V, Prothrombin, MTHFR for clotting disorders).

Dr. Roger Hodkinson, a clinical pathologist with MultiGEN Diagnostics comments, "MultiGEN is pioneering the concept of 'Syndrome Driven(TM)' test panels for the simultaneous detection of multiple DNA targets". He further adds, "The proprietary test platform has verifiable accuracy, and with its automated off-the-shelf liquid handling systems and genetic analyzers, it enables to decrease the hands-on technical time, minimize human error, and reduce the overall cost."

"MultiGEN Diagnostics accepts a variety of samples for its tests including buccal swabs, and the results are reported within a day. This platform technology is flexible enough to launch new test menus within weeks, and detect ever changing microbial virulence, including H1N1, HIV, and MRSA," says Dr. Linda Wasserman, Medical Director of MultiGen Diagnostics.


'/>"/>
SOURCE MultiGEN Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Use of certain lipid measures not more effective in predicting coronary heart disease
3. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
4. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
5. Stanford study highlights cost-effective method of lowering heart disease risks
6. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
7. Case Management Cost-Effective Way to Cut Heart Risks
8. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
9. Nasal Anthrax Vaccine Proves Effective in Animal Study
10. Family-based treatment more effective than supportive psychotherapy in treating bulimia
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology: